Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142307 |
| CAS No | NA |
| Mol.F. | C31H39N7O10S2 |
| Mol.Wt. | 733.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142308 |
| CAS No | NA |
| Mol.F. | C31H39N7O10S2 |
| Mol.Wt. | 733.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142309 |
| CAS No | NA |
| Mol.F. | C32H37N7O11S2 |
| Mol.Wt. | 759.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142310 |
| CAS No | NA |
| Mol.F. | C48H56N10O16S3 |
| Mol.Wt. | 1125.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142311 |
| CAS No | NA |
| Mol.F. | C24H28N6O8S2 |
| Mol.Wt. | 592.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142312 |
| CAS No | NA |
| Mol.F. | C24H30N6O9S2 |
| Mol.Wt. | 610.66 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142313 |
| CAS No | NA |
| Mol.F. | C21H32N2O11 |
| Mol.Wt. | 488.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142314 |
| CAS No | NA |
| Mol.F. | C11H14N2O3 |
| Mol.Wt. | 222.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142315 |
| CAS No | NA |
| Mol.F. | C18H21BrN2O4 |
| Mol.Wt. | 409.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142316 |
| CAS No | NA |
| Mol.F. | C18H21IN2O4 |
| Mol.Wt. | 456.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142317 |
| CAS No | NA |
| Mol.F. | C20H26N2O4 |
| Mol.Wt. | 358.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142318 |
| CAS No | NA |
| Mol.F. | C18H21ClN2O4 |
| Mol.Wt. | 364.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142319 |
| CAS No | NA |
| Mol.F. | C17H19IN2O4 |
| Mol.Wt. | 442.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142320 |
| CAS No | NA |
| Mol.F. | C19H24N2O4 |
| Mol.Wt. | 344.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142321 |
| CAS No | NA |
| Mol.F. | C17H19BrN2O4 |
| Mol.Wt. | 395.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142322 |
| CAS No | NA |
| Mol.F. | C17H19ClN2O4 |
| Mol.Wt. | 350.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |